United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025
- DPI3199062
- 95 Pages
- June 2019
- Pharmaceuticals
“United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the actual market situation and future outlook for United States pneumococcal & meningococcal vaccines market. The report includes historical data from 2015 to 2018 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the United States pneumococcal & meningococcal vaccines market. The report also explores detailed analysis of top 6 vaccines market assessment in United States from 2015 to 2018 and forecasts to 2025. The report also details the latest information about the pneumococcal & meningococcal vaccines pricing trends and analysis. It also covers reimbursement pattern and offers a clear view of the regulatory landscape.
Additionally, the report includes assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive, licensing agreement and partnerships are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States pneumococcal & meningococcal vaccines market.
The report concludes with the profiles of major players in the United States pneumococcal & meningococcal vaccines market. The key market players are evaluated on various parameters such as business overview, vaccines portfolio and recent development.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
Pfizer, Merck, Sanofi Pasteur and GlaxoSmithKline (GSK)
Top 6 Vaccines Covered Under This Report Are:
• Prevnar / Prevnar 13
• Pneumovax 23
• Menactra
• Bexsero
• Menveo
• Trumenba
The Latest Industry Data Included in this Report:
• United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
• United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
• United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
• United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
• United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
• United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies
• United States Pneumococcal & Meningococcal Vaccines Regulatory System
• Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
• Major Deals in the Vaccines Market
• Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
• Major Companies Analysis
The Report Answers the Following Questions about the United States Pneumococcal & Meningococcal Vaccines Market:
• What is the size of the United States pneumococcal & meningococcal vaccines market during 2015 – 2025?
• What will be the revenue generated by each vaccine during the forecast period?
• Which vaccine provides highest market share?
• How are the overall market and vaccines type growing?
• What are the key drivers and inhibitors in the current market?
• What are the various pneumococcal & meningococcal vaccines available in the United States?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?
2. United States Pneumococcal & Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
3. United States Pneumococcal Vaccines Market Size & Analysis (2015 – 2025)
4. United States Meningococcal Vaccines Market Size & Analysis (2015 – 2025)
5. United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
5.1 United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (%), 2015 – 2025
5.2 United States Meningococcal Vaccines Market Share & Y–o–Y Growth (%), 2017 – 2025
6. Key Drivers and Inhibitors of the United States Pneumococcal & Meningococcal Vaccines Market
6.1 Market Drivers
6.2 Market Inhibitors
7. United States Pneumococcal & Meningococcal Vaccines Market Assessment & Opportunity (Value),2015 – 2025
7.1 Prevnar / Prevnar 13
7.2 Pneumovax 23
7.3 Menactra
7.4 Bexsero
7.5 Menveo
7.6 Trumenba
8. United States Pneumococcal & Meningococcal Vaccines Pricing Trends & Analysis
9. United States Pneumococcal & Meningococcal Vaccines Reimbursement Policies & Regulatory System
9.1 Reimbursement Policies
9.2 Regulation System
10. Promising Pneumococcal & Meningococcal Vaccines in Clinical Development
11. Major Deals in the Vaccines Market
11.1 Merger & Acquisitions
11.2 Collaboration Deals
11.3 Licensing Agreement
11.4 Exclusive Agreement
11.5 Distribution Agreement
11.6 Partnerships
12. Key Companies Analysis
12.1 Sanofi Pasteur
12.1.1 Business Overview
12.1.2 Vaccines Portfolio
12.1.3 Recent Development
12.2 GlaxoSmithKline (GSK)
12.2.1 Business Overview
12.2.2 Vaccines Portfolio
12.2.3 Recent Development
12.3 Merck
12.3.1 Business Overview
12.3.2 Vaccines Portfolio
12.3.3 Recent Development
12.4 Pfizer
12.4.1 Business Overview
12.4.2 Vaccines Portfolio
12.4.3 Recent Development
Table 5–1: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–2: United States Pneumococcal & Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–3: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2015 – 2018
Table 5–4: United States Pneumococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 5–5: United States Meningococcal Vaccines Market Share & Y–o–Y Growth (Percent), 2017 – 2018
Table 5–6: United States Meningococcal Vaccines Market Share & Y–o–Y Growth Forecast (Percent), 2019 – 2025
Table 8–1: United States Pneumococcal & Meningococcal Adult Vaccines Price, 2019 – 2020
Table 8–2: United States Pneumococcal & Meningococcal Pediatric Vaccines Price, 2019 – 2020
Table 9–1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 11–1: Merger & Acquisitions in the Vaccines Market
Table 11–2: Collaboration Deal in the Vaccines Market
Table 11–3: Licensing Agreement in the Vaccines Market
Table 11–4: Exclusive Agreement in the Vaccines Market
Table 11–5: Distribution Agreement in the Vaccines Market
Table 6–6: Partnerships in the Vaccines Market
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
